Ventas Life Science & Healthcare Real Estate Fund, L.P.

Other real estate
Rule 506(b)
Chicago, Illinois
Amended Oct 16, 2026

Raising: Indefinite; No set size
Sold so far: $2,090,987,398
Investors: 32
Average check: $65,343,356; Sold ÷ investors
Minimum: $25,000,000
Sales commissions: $16,561,668; Issuer's estimate

In plain English

Ventas Life Science & Healthcare Real Estate Fund, L.P., a real estate business based in Chicago, Illinois, filed an amended Form D with the SEC on Oct 16, 2026 for an offering with no set size. It reports about $2.1 billion raised from 32 investors. That works out to roughly $65,343,000 per investor. The smallest investment it accepts from an outside investor is $25,000,000.

It filed under Rule 506(b), which means the offering can't be advertised to the public. Investors in these deals usually already have a relationship with the sponsor.

How it compares

Against the 594 real estate offerings filed Oct 6 – Nov 4, 2026.

This offeringMedian

Raise sizeIndefinite vs $7.7M median

No set size, so it can't be ranked against the 460 offerings that set one.

How much is sold$2.1B sold

With no set size there's no share sold to compare.

Minimum investment$25,000,000 vs $50,000 median

Higher than 100% of the 427 offerings that stated a minimum.

Where the sponsor is based

The Illinois housing market

Typical home value $296KChange, 12 months 5.3%Chicago metro $356K

Form D lists the issuer's principal place of business, not where its properties are. Home values for Sep 2026.

See Illinois market data

Filing details

File number: 021-362702
Latest filing: Form D/A (amendment), Oct 16, 2026
Accession number: 0001805621-26-000002
Entity type: Limited Partnership
Industry group: Other Real Estate
Principal place of business: Chicago, Illinois
Exemption claimed: Rule 506(b)
First sale: Mar 1, 2020

Timeline

First sale
Mar 1, 2020
Latest amendment (Form D/A) filed
Oct 16, 2026
$2.1B sold
As reported Oct 16, 2026

Other recent filings from Illinois

All fund filings

This page summarizes a notice Ventas Life Science & Healthcare Real Estate Fund, L.P. filed with the SEC. Fidelis First is not affiliated with Ventas Life Science & Healthcare Real Estate Fund, L.P., has not reviewed this offering and does not recommend it. Nothing here is an offer to sell or a solicitation of an offer to buy any security. Figures are as the issuer reported them on Oct 16, 2026 and may have changed since.

Sales commissions are the issuer's estimate for the whole offering, not amounts paid so far. Average check is derived: amount sold divided by number of investors. Issuers don't have to amend a Form D when sales or investor counts change, so these can lag.

Source: SEC EDGAR, Form D · As of Oct 16, 2026

Source: Data Provided by Zillow Group · As of Sep 2026